Immunomodulatory Peptide LW‐9 Enhances Doxorubicin Efficacy by Downregulating PD‐L1 and Promoting Intratumoral T‐Cell Responses in Murine Breast Cancer
Immunology · 25.10.2026
DOI: 10.1111/imm.70214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, online erschienen am 25.10.2026. Verfasst von Ingrid Mayara Cavalcante Trevisan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
Spider venom‐derived peptides have emerged as promising therapeutic agents due to their high specificity and ability to modulate cellular and immunological pathways. LW‐9, a peptide isolated from Phoneutria nigriventer venom, was identified as a potential immunomodulatory molecule with antitumor activity. This study evaluated the therapeutic effects of LW‐9 in a murine breast cancer model using EO771 cells. Treatment with LW‐9 significantly delayed tumour progression, with enhanced efficacy observed when combined with the chemotherapeutic agent doxorubicin. The therapeutic dose of LW‐9 (1 μg/kg) showed a favourable safety profile, with no significant alterations in hepatic or renal biochemical markers, including AST, ALT, creatinine, and urea. In addition, LW‐9 improved animal well‐being, as indicated by increased food intake and maintenance of body weight compared with doxorubicin‐treated controls. Immunological analyses demonstrated that LW‐9, particularly in combination with doxorubicin, promoted substantial remodelling of the tumour microenvironment. Flow cytometry revealed reduced PD‐L1 expression and increased frequencies of CD3 + and CD3 + /GITR + T cells, indicating enhanced antitumor immune activation. Immunohistochemical analysis confirmed increased lymphocytic infiltration within tumour tissue. Tumours maintained a stable ER‐negative, PR‐positive, HER2‐negative, and EGFR‐positive phenotype across all groups, suggesting that LW‐9‐mediated antitumor activity occurs independently of classical molecular subtype alterations. Collectively, these findings demonstrate that LW‐9 enhances chemotherapy efficacy by modulating the tumour immune microenvironment, supporting its potential as a novel immunoadjuvant strategy for breast cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
- Department of Structural and Functional Biology, Institute of Biology, Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
ORCID-Profile: Ingrid Mayara Cavalcante Trevisan, Cibele Pereira Mariano, Sabrina Carvalho Brunelli, Gabriel da Silva Cordeiro, Valquiria Aparecida Matheus, Catarina Rapôso
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Zitieren
APA
Trevisan, I. M. C., Mariano, C. P., Brunelli, S. C., Cordeiro, G. D. S., Takaki, J., Matheus, V. A., Verinaud, L., & Rapôso, C. (2026). Immunomodulatory Peptide LW‐9 Enhances Doxorubicin Efficacy by Downregulating PD‐L1 and Promoting Intratumoral T‐Cell Responses in Murine Breast Cancer. Immunology. https://doi.org/10.1111/imm.70214
Vancouver
Trevisan IMC, Mariano CP, Brunelli SC, Cordeiro GDS, Takaki J, Matheus VA, et al. Immunomodulatory Peptide LW‐9 Enhances Doxorubicin Efficacy by Downregulating PD‐L1 and Promoting Intratumoral T‐Cell Responses in Murine Breast Cancer. Immunology. 2026. doi:10.1111/imm.70214
BibTeX
@article{Trevisan2026,
author = {Trevisan, Ingrid Mayara Cavalcante and Mariano, Cibele Pereira and Brunelli, Sabrina Carvalho and Cordeiro, Gabriel da Silva and Takaki, Jessika and Matheus, Valquiria Aparecida and Verinaud, Liana and Rapôso, Catarina},
title = {Immunomodulatory Peptide LW‐9 Enhances Doxorubicin Efficacy by Downregulating PD‐L1 and Promoting Intratumoral T‐Cell Responses in Murine Breast Cancer},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70214}
}
EUVIMED